A new approach to early diagnosis of congestive heart failure disease by using Hilbert-Huang transform

Gokhan Altan1, Yakup Kutlu2, Novruz Allahverdi3

  • 1Mustafa Kemal University, Antakya, Turkey.

Insights

This study introduces a novel system for diagnosing congestive heart failure (CHF) and coronary artery disease (CAD) using electrocardiogram (ECG) data. The method achieves high accuracy in identifying both conditions and enabling early CHF detection through CAD analysis.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Signal Processing

Background:

  • Congestive heart failure (CHF) is a significant cardiac condition often caused by coronary artery disease (CAD).
  • Accurate and early diagnosis of CHF and CAD is crucial for patient outcomes.
  • Non-linear and non-stationary signal analysis offers potential for improved diagnostic capabilities.

Purpose of the Study:

  • To develop and validate a system for the simultaneous diagnosis of CHF and CAD.
  • To investigate the feasibility of early CHF diagnosis by analyzing CAD indicators.
  • To leverage advanced signal processing techniques for enhanced cardiac disease detection.

Main Methods:

  • Utilized the Hilbert-Huang transform (HHT) to analyze R-R intervals from electrocardiogram (ECG) data.
  • Extracted statistical features from intrinsic mode functions derived via HHT.
  • Employed a multilayer perceptron neural network for classification of CHF, CAD, and control groups.

Main Results:

  • The system achieved high diagnostic performance: 97.83% accuracy, 93.79% specificity, and 100% sensitivity for CHF and CAD.
  • Early diagnosis of CHF through CAD interpretation showed excellent results with 97.53% accuracy, 98.18% specificity, and 97.13% sensitivity.
  • Demonstrated the integration of CAD diagnosis into a unified system for both diagnosis and early detection of CHF.

Conclusions:

  • A novel integrated system effectively diagnoses both CHF and CAD using ECG R-R interval analysis.
  • The proposed method enables early detection of CHF by accurately interpreting associated CAD.
  • This approach offers a promising tool for comprehensive cardiac disease management and patient care.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
505
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
593
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.3K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
373
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
689